The concomitant utilization of buprenorphine and CYP3A4 inducers can lessen the plasma concentration of buprenorphine [see CLINICAL PHARMACOLOGY], possibly resulting in lessened efficacy or onset of the withdrawal syndrome in individuals who have formulated Actual physical dependence to buprenorphine.Will not abruptly cease applying this medicine w